To identify the underlying mechanisms involved in driving the distinct pathogenesis observed in PsA and RA, and to define how these impacts on therapeutic response
High-throughput sequencing of inherited and multifactorial macula disease associated genes and risk factors allows identification of genetic interactions and modifiers
Innovative plant protein fibre and physical activity solutions to address poor appetite and prevent undernutrition in older adults
Development of pharmacological chaperones stabilizing FGE for therapeutic intervention in Multiple Sulfatase Deficiency
Safeguarding the Brain Of Our Smallest Children – an open-label phase-III randomised trial of cerebral oximetry combined with a treatment guideline versus treatment as usual in premature infants
Expanding the lung donor pool: interventions to improve donor management, expand ex vivo lung perfusion and repair injured donor lungs
